News Releases

News and information from The Leukemia & Lymphoma Society

How One Family’s Loss 70 Years Ago Inspires Students to Fight Cancer Today

(Rye Brook, NY, June 19, 2019) – The Leukemia & Lymphoma Society (LLS) was founded 70 years ago by parents who lost their 16-year-old son to leukemia. Today, 1,000s of passionate, resourceful and driven high school students across the country are reinventing LLS for a new generation, as they honor the legacy of an organization founded by a family for families. Through their participation in LLS’s ...

Subaru and LLS Spread Hope & Warmth to Cancer Patients Nationwide

Rye Brook, NY (June 3, 2019) – Subaru of America, Inc. and The Leukemia & Lymphoma Society (LLS), two organizations committed to positively impacting the communities where they live and work, have partnered once again to send hope, love and warmth to patients fighting cancer. With the goal of donating more simple comforts to more patients year after year, Subaru and LLS aim to achieve a new record in partic...

Families Fighting for Cancer Cures: Generation LLS

Click here to view full multimedia release. Rye Brook, NY (May 22, 2019) – As an organization founded by a family for families, The Leukemia & Lymphoma Society (LLS) is celebrating 70 years of impact on generations of families, researchers and volunteers while looking to the future by redoubling its commitment to improve treatments and care for children with cancer. To accomplish its bold vision for child...

Generations of Impact: Ensuring New Cancer Treatments for Those to Come

View on PR Newswire here.  Rye Brook, NY - March 20, 2019 – Everyone loves a little friendly competition, especially if the reward is saving lives and keeping families together. The Leukemia & Lymphoma Society (LLS), the world’s largest nonprofit dedicated to fighting blood cancer, knows all too well the devastation cancer causes for families and communities. LLS has kicked off its 30th annu...

Congress Introduces Cancer Drug Parity Act

Washington, DC (March 13, 2019) – The Leukemia & Lymphoma Society (LLS) is proud to support the Cancer Drug Parity Act, which will remove a key financial barrier that prevents some patients from accessing their prescribed cancer treatments. This bipartisan legislation was reintroduced today in the U.S. House of Representatives by Representative Brian Higgins (D-N.Y.), Representative Brett Guthrie (R-Ky.), Repre...

LLS OFFERS 30 SOLUTIONS TO DECREASE HEALTHCARE COSTS FOR PATIENTS

Rye Brook, N.Y. (Mar. 1, 2019) — As costs for cancer care skyrocket,  The Leukemia & Lymphoma Society® (LLS) is putting forward 31 policy recommendations aimed at lowering the cost of cancer care for patients, while protecting access to quality care. Louis J. DeGennaro, Ph.D., LLS president and CEO, issued the following statement regarding the cost of cancer care: “The hig...

LLS Continues to Drive Progress to Cancer Cures

(Rye Brook, NY, Jan. 15 2019) – Groundbreaking advances that harness the body’s immune system to attack cancer cells are set to continue, as well as significant focus on new therapies for children with cancer. And expect the revolution to gain steam in cancer treatments moving away from toxic chemotherapy toward genetics-driven targeted therapies, the foundation of precision medicine.  This according to L...

U.S. Senate Introduces Cancer Drug Parity Act

Washington, DC (December 12, 2018) – The Leukemia & Lymphoma Society (LLS) is proud to support the Cancer Drug Parity Act, which will ensure equality of insurance coverage for all cancer treatments, regardless of how these treatments are administered. This bipartisan legislation was introduced today in the U.S. Senate by Senator Tina Smith (D-Minn.), Senator Jerry Moran (R-Kan.), Senator Chris Murphy (D-Conn.) ...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: